Home / Inspections / 1195646

FDA Inspection 1195646 — Megafine Pharma (P) Limited

Megafine Pharma (P) Limited — FEI 3005694111

The FDA completed an inspection of Megafine Pharma (P) Limited on January 24, 2023 in Nashik. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Nashik (India)

Facility

Other inspections at this facility

  • 1122874 (OAI Fri Mar 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1054711 (OAI Sat May 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929021 (OAI Fri May 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730085 (NAI Thu Jun 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources